####################
# Output from PRIME (v2.0)
# Alleles: A0201
# Affinity predictions: MixMHCpred (/Users/annieborch/Documents/programs/MixMHCpred-master/MixMHCpred)
# Input file: /Users/annieborch/Documents/IMPROVE/IMPROVE_git/IMPROVE_tool/results/predictions/PRIME/tempPept.txt
#
# PRIME is freely available for academic users.
# Private companies should contact Nadette Bulgin (nbulgin@lcr.org) at the Ludwig Institute for Cancer Research Ltd for commercial licenses.
# To cite PRIME2.0, please refer to:
# Gfeller et al. Predictions of immunogenicity reveal potent SARS-Cov-2 CD8 T-cell epitopes, BioRxiv (2022).
####################
Peptide	%Rank_bestAllele	Score_bestAllele	%RankBinding_bestAllele	BestAllele	%Rank_A0201	Score_A0201	%RankBinding_A0201
FLPAGVRMV	0.297	0.090223	0.369	A0201	0.297	0.090223	0.369
LLWMGVLAL	0.211	0.107884	0.296	A0201	0.211	0.107884	0.296
SLDLHFTDV	0.137	0.132799	0.545	A0201	0.137	0.132799	0.545
AALPGVPPV	0.670	0.053443	0.555	A0201	0.670	0.053443	0.555
KLLSLSGVLAV	0.261	0.097021	0.030	A0201	0.261	0.097021	0.030
YLFEHCSYGVI	1.136	0.036422	0.460	A0201	1.136	0.036422	0.460
YLWEKECSVP	8.634	0.005243	3.465	A0201	8.634	0.005243	3.465
ALSGFYSLL	0.095	0.154520	0.586	A0201	0.095	0.154520	0.586
FLSRELDGRL	4.759	0.009785	2.487	A0201	4.759	0.009785	2.487
RIFWPTKTI	3.852	0.012039	2.656	A0201	3.852	0.012039	2.656
LLVPASQHL	0.434	0.072165	0.155	A0201	0.434	0.072165	0.155
KVIDEEWQI	0.294	0.090759	0.126	A0201	0.294	0.090759	0.126
LLIFFLFIVVI	1.507	0.029208	8.592	A0201	1.507	0.029208	8.592
